Abbruzzese JL et al: Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13:2094, 1995

Abbruzzese JL et al: Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272, 1994

Casciato DA. Metastases of unknown origin. In: Haskell CM, ed. Cancer Treatment, 5th ed., chapter 102, pp. 1556-1578. Philadelphia, PA: WB Saunders, 2001.

De Braud F, Al-Serraf M: Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 20:273, 1993

Ellerbroek N et al: Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 66:1461, 1990

Fletcher JA et al: Diagnostic relevance of clonal cytogenetics in malignant soft tissue tumors. N Engl J Med 324:436, 1991

Giordano TJ, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001; 159:1231.

Greco FA, et al. Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer J 2001; 7:203.

Greco FA, et al. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol 2002; 20:1651.

Hainsworth JD, Greco FA Treatment of patients with cancer of an unknown primary site. N Engl J Med 329:257, 1993

Horning SJ et al: Lymphomas presenting as histologically unclassified neoplasms: Characteristics and response to treatment. J Clin Oncol 17:1281, 1989

Kemeny MM. Mastectomy: is it necessary for occult breast cancer? NY State J Med 1992; 92:516.

Le Chevalier T, et al. Early metastatic cancer of unknown primary presentation: a clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148:2035.

Moertel CG et al: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: Evidence of major therapeutic activity in the anaptastic variety of these neoplasms. Cancer 68:227, 1991

Motzer RJ et al: Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 13:274, 1995

Muggia FM, Baranda J: Management of peritoneal carcinomatosis of unknown primary tumor site. Semin Oncol 20:268, 1993

Nystrom JS, et al. Identifying the primary site in metastatic cancer of unknown origin. JAMA 1979; 241:381.

Pavlidis N, et al. Evaluation of six tumor markers in patients with carcinoma of unknown primary. Med Pediatr Oncol 1994; 22:162.

Sporn JR, Greenberg BR: Empirical chemotherapy for adenocarcinoma of unknown primary tumor site. Semin Oncol 20:261, 1993


  • :